Literature DB >> 24355598

The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.

Takenari Yamashita1, Shin Kwak2.   

Abstract

TAR DNA-binding protein (TDP-43) pathology and reduced expression of adenosine deaminase acting on RNA 2 (ADAR2), which is the RNA editing enzyme responsible for adenosine-to-inosine conversion at the GluA2 glutamine/arginine (Q/R) site, concomitantly occur in the same motor neurons of amyotrophic lateral sclerosis (ALS) patients; this finding suggests a link between these two ALS-specific molecular abnormalities. AMPA receptors containing Q/R site-unedited GluA2 in their subunit assembly are Ca(2+)-permeable, and motor neurons lacking ADAR2 undergo slow death in conditional ADAR2 knockout (AR2) mice, which is a mechanistic ALS model in which the ADAR2 gene is targeted in cholinergic neurons. Moreover, deficient ADAR2 induced mislocalization of TDP-43 similar to TDP-43 pathology seen in the sporadic ALS patients in the motor neurons of AR2 mice. The abnormal mislocalization of TDP-43 specifically resulted from activation of the Ca(2+)-dependent serine protease calpain that specifically cleaved TDP-43 at the C-terminal region, and generated aggregation-prone N-terminal fragments. Notably, the N-terminal fragments of TDP-43 lacking the C-terminus were demonstrated in the brains and spinal cords of ALS patients. Because normalization of either the Ca(2+)-permeability of AMPA receptors or the calpain activity in the motor neurons normalized the subcellular localization of TDP-43 in AR2 mice, it is likely that exaggerated calpain-dependent TDP-43 fragments played a role at least in the initiation of TDP-43 pathology. Elucidation of the molecular cascade of neuronal death induced by ADAR2 downregulation could provide a new specific therapy for sporadic ALS. In this review, we summarized the work from our group on the role of inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in sporadic ALS, and discussed possible effects of inefficient ADAR2-mediated RNA editing in general.
Copyright © 2013 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AMPA receptor; Adenosine deaminase acting on RNA 2 (ADAR2); Amyotrophic lateral sclerosis (ALS); Calpain; GluA2; RNA editing; TAR DNA binding protein of 43kDa (TDP-43)

Mesh:

Substances:

Year:  2013        PMID: 24355598     DOI: 10.1016/j.brainres.2013.12.011

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  32 in total

Review 1.  Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era.

Authors:  Ximena Paez-Colasante; Claudia Figueroa-Romero; Stacey A Sakowski; Stephen A Goutman; Eva L Feldman
Journal:  Nat Rev Neurol       Date:  2015-04-21       Impact factor: 42.937

2.  Motor neuron degeneration following glycine-mediated excitotoxicity induces spastic paralysis after spinal cord ischemia/reperfusion injury in rabbit.

Authors:  Li Wang; Sen Li; Yuan Liu; Dong-Liang Feng; Long Jiang; Zai-Yun Long; Ya-Min Wu
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

Review 3.  Linking RNA Dysfunction and Neurodegeneration in Amyotrophic Lateral Sclerosis.

Authors:  Sami J Barmada
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

4.  Calpain-Dependent Degradation of Nucleoporins Contributes to Motor Neuron Death in a Mouse Model of Chronic Excitotoxicity.

Authors:  Kaori Sugiyama; Tomomi Aida; Masatoshi Nomura; Ryoichi Takayanagi; Hanns U Zeilhofer; Kohichi Tanaka
Journal:  J Neurosci       Date:  2017-08-16       Impact factor: 6.167

Review 5.  The Role of TDP-43 in Alzheimer's Disease.

Authors:  Xiao-Long Chang; Meng-Shan Tan; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2015-06-17       Impact factor: 5.590

Review 6.  Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis.

Authors:  Mariana Pehar; Benjamin A Harlan; Kelby M Killoy; Marcelo R Vargas
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

Review 7.  Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.

Authors:  Alexander Starr; Rita Sattler
Journal:  Brain Res       Date:  2018-02-14       Impact factor: 3.252

8.  Bcl-2/Bax expression levels tend to influence AMPAergic trafficking mechanisms during hibernation in Mesocricetus auratus.

Authors:  Maria Mele; Raffaella Alò; Ennio Avolio; Marcello Canonaco
Journal:  J Mol Neurosci       Date:  2014-06-01       Impact factor: 3.444

Review 9.  Synaptic AMPA receptor composition in development, plasticity and disease.

Authors:  Jeremy M Henley; Kevin A Wilkinson
Journal:  Nat Rev Neurosci       Date:  2016-04-15       Impact factor: 34.870

10.  Sorting nexin-27 regulates AMPA receptor trafficking through the synaptic adhesion protein LRFN2.

Authors:  Kirsty J McMillan; Paul J Banks; Francesca Ln Hellel; Ruth E Carmichael; Thomas Clairfeuille; Ashley J Evans; Kate J Heesom; Philip Lewis; Brett M Collins; Zafar I Bashir; Jeremy M Henley; Kevin A Wilkinson; Peter J Cullen
Journal:  Elife       Date:  2021-07-12       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.